LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, announced that its GastroPlus™ software for simulation of oral absorption, pharmacokinetics, and pharmacodynamics was the top-rated software in a comparison study performed by Pfizer (NYSE:PFE).
